

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.34914946 |
| 2 | endothelial cell chemotaxis (GO:0035767) | 5.05328899 |
| 3 | regulation of gamma-delta T cell activation (GO:0046643) | 4.85421540 |
| 4 | tolerance induction (GO:0002507) | 4.27018012 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.25119605 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.23290714 |
| 7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.11809277 |
| 8 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.09690947 |
| 9 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 4.09058804 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.99769295 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79964652 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79964652 |
| 13 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.73455790 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.73455163 |
| 15 | thymic T cell selection (GO:0045061) | 3.67124334 |
| 16 | lymph vessel development (GO:0001945) | 3.66916357 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 3.65490488 |
| 18 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.65200414 |
| 19 | adherens junction assembly (GO:0034333) | 3.64736516 |
| 20 | regulation of chromatin binding (GO:0035561) | 3.55227232 |
| 21 | response to muramyl dipeptide (GO:0032495) | 3.51205049 |
| 22 | interferon-gamma production (GO:0032609) | 3.48349056 |
| 23 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44574314 |
| 24 | negative T cell selection (GO:0043383) | 3.43974168 |
| 25 | negative thymic T cell selection (GO:0045060) | 3.42131102 |
| 26 | heart trabecula formation (GO:0060347) | 3.41723131 |
| 27 | positive T cell selection (GO:0043368) | 3.40213764 |
| 28 | sodium ion export (GO:0071436) | 3.34522044 |
| 29 | response to interleukin-15 (GO:0070672) | 3.34446639 |
| 30 | heart valve formation (GO:0003188) | 3.32293808 |
| 31 | T cell selection (GO:0045058) | 3.28351986 |
| 32 | growth hormone receptor signaling pathway (GO:0060396) | 3.15189584 |
| 33 | cellular protein complex localization (GO:0034629) | 3.14427823 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 3.13871830 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.11475800 |
| 36 | ear development (GO:0043583) | 3.10310520 |
| 37 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.09458436 |
| 38 | ventricular septum morphogenesis (GO:0060412) | 3.09339353 |
| 39 | notochord development (GO:0030903) | 3.03912636 |
| 40 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.95641589 |
| 41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.95048565 |
| 42 | muscle filament sliding (GO:0030049) | 2.94858043 |
| 43 | actin-myosin filament sliding (GO:0033275) | 2.94858043 |
| 44 | cardiac myofibril assembly (GO:0055003) | 2.93735006 |
| 45 | response to laminar fluid shear stress (GO:0034616) | 2.93712194 |
| 46 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.93048656 |
| 47 | focal adhesion assembly (GO:0048041) | 2.89955966 |
| 48 | cell-substrate adherens junction assembly (GO:0007045) | 2.89955966 |
| 49 | valine metabolic process (GO:0006573) | 2.88413435 |
| 50 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.87905135 |
| 51 | atrioventricular valve morphogenesis (GO:0003181) | 2.87373439 |
| 52 | positive regulation of interleukin-2 production (GO:0032743) | 2.86953938 |
| 53 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.85453669 |
| 54 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.84022637 |
| 55 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.84022637 |
| 56 | paraxial mesoderm development (GO:0048339) | 2.83754481 |
| 57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80925851 |
| 58 | mammary gland epithelial cell differentiation (GO:0060644) | 2.80575812 |
| 59 | endocardial cushion morphogenesis (GO:0003203) | 2.80555900 |
| 60 | non-canonical Wnt signaling pathway (GO:0035567) | 2.78371251 |
| 61 | T cell migration (GO:0072678) | 2.76771288 |
| 62 | T-helper cell differentiation (GO:0042093) | 2.76425535 |
| 63 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.76425535 |
| 64 | myofibril assembly (GO:0030239) | 2.74471945 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 2.74259187 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 2.74171262 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73291308 |
| 68 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.73138094 |
| 69 | negative regulation of cell killing (GO:0031342) | 2.73138094 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69956904 |
| 71 | regulation of establishment of planar polarity (GO:0090175) | 2.68799107 |
| 72 | cellular response to growth hormone stimulus (GO:0071378) | 2.68364552 |
| 73 | regulation of p38MAPK cascade (GO:1900744) | 2.68244171 |
| 74 | aorta morphogenesis (GO:0035909) | 2.67824388 |
| 75 | positive regulation of mRNA catabolic process (GO:0061014) | 2.66708630 |
| 76 | negative regulation of myoblast differentiation (GO:0045662) | 2.65533325 |
| 77 | positive regulation of lipid storage (GO:0010884) | 2.63988104 |
| 78 | trabecula formation (GO:0060343) | 2.62992581 |
| 79 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.62654319 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 2.61928603 |
| 81 | positive regulation of p38MAPK cascade (GO:1900745) | 2.61346512 |
| 82 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.61214984 |
| 83 | skeletal muscle contraction (GO:0003009) | 2.60958945 |
| 84 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.59915503 |
| 85 | camera-type eye morphogenesis (GO:0048593) | 2.59722348 |
| 86 | positive regulation of fatty acid oxidation (GO:0046321) | 2.58862009 |
| 87 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.58699775 |
| 88 | leukocyte aggregation (GO:0070486) | 2.58463677 |
| 89 | lipid storage (GO:0019915) | 2.58332153 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.57641324 |
| 91 | regulation of cholesterol storage (GO:0010885) | 2.56884008 |
| 92 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.56622719 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56578098 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 2.56557933 |
| 95 | kidney mesenchyme development (GO:0072074) | 2.55763140 |
| 96 | mesenchyme morphogenesis (GO:0072132) | 2.55181287 |
| 97 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.55015509 |
| 98 | heart valve morphogenesis (GO:0003179) | 2.53982943 |
| 99 | convergent extension (GO:0060026) | 2.53416835 |
| 100 | carnitine shuttle (GO:0006853) | 2.52487674 |
| 101 | negative regulation of lipid storage (GO:0010888) | 2.52198693 |
| 102 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.51576635 |
| 103 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.51010804 |
| 104 | fatty acid transmembrane transport (GO:1902001) | 2.50493811 |
| 105 | myeloid dendritic cell activation (GO:0001773) | 2.50437350 |
| 106 | cardiac muscle adaptation (GO:0014887) | 2.49685251 |
| 107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.49685251 |
| 108 | muscle hypertrophy in response to stress (GO:0003299) | 2.49685251 |
| 109 | regulation of response to interferon-gamma (GO:0060330) | 2.49594791 |
| 110 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49245662 |
| 111 | cellular extravasation (GO:0045123) | 2.49162316 |
| 112 | creatine metabolic process (GO:0006600) | 2.48697148 |
| 113 | activation of MAPKKK activity (GO:0000185) | 2.48440771 |
| 114 | protein complex localization (GO:0031503) | 2.48298578 |
| 115 | negative regulation of granulocyte differentiation (GO:0030853) | 2.47964277 |
| 116 | cerebellar granule cell differentiation (GO:0021707) | 2.47522621 |
| 117 | negative regulation of catenin import into nucleus (GO:0035414) | 2.47498755 |
| 118 | cochlea morphogenesis (GO:0090103) | 2.47033767 |
| 119 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.46713199 |
| 120 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.45408056 |
| 121 | developmental induction (GO:0031128) | 2.45375904 |
| 122 | actin-mediated cell contraction (GO:0070252) | 2.44689847 |
| 123 | mammary gland development (GO:0030879) | 2.44405087 |
| 124 | cell-cell junction maintenance (GO:0045217) | 2.44097625 |
| 125 | negative regulation of fatty acid transport (GO:2000192) | 2.44072893 |
| 126 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.42778381 |
| 127 | Notch signaling involved in heart development (GO:0061314) | 2.42399862 |
| 128 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.41378392 |
| 129 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.41123622 |
| 130 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.41123622 |
| 131 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.40615262 |
| 132 | pattern specification involved in kidney development (GO:0061004) | 2.40574002 |
| 133 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.40210078 |
| 134 | regulation of B cell differentiation (GO:0045577) | 2.39244793 |
| 135 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.39095802 |
| 136 | cardiac muscle cell proliferation (GO:0060038) | 2.38687198 |
| 137 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 2.38517773 |
| 138 | regulation of heart morphogenesis (GO:2000826) | 2.37814401 |
| 139 | ovulation from ovarian follicle (GO:0001542) | 2.37755116 |
| 140 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.37596483 |
| 141 | myotube differentiation (GO:0014902) | 2.37285455 |
| 142 | regulation of mRNA catabolic process (GO:0061013) | 2.37207522 |
| 143 | T cell receptor signaling pathway (GO:0050852) | 2.37181158 |
| 144 | cardiac muscle hypertrophy (GO:0003300) | 2.37036774 |
| 145 | embryonic process involved in female pregnancy (GO:0060136) | 2.36771008 |
| 146 | T cell differentiation involved in immune response (GO:0002292) | 2.36672699 |
| 147 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.36672699 |
| 148 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.36672699 |
| 149 | blood vessel endothelial cell migration (GO:0043534) | 2.35970957 |
| 150 | metanephric mesenchyme development (GO:0072075) | 2.35248297 |
| 151 | negative regulation of inclusion body assembly (GO:0090084) | 2.35160686 |
| 152 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.33767020 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.33349379 |
| 154 | nephron tubule formation (GO:0072079) | 2.32877292 |
| 155 | negative regulation of bone resorption (GO:0045779) | 2.32601777 |
| 156 | respiratory system process (GO:0003016) | 2.32591135 |
| 157 | cardiac septum morphogenesis (GO:0060411) | 2.31713270 |
| 158 | negative regulation of innate immune response (GO:0045824) | 2.31513279 |
| 159 | peripheral nervous system axon ensheathment (GO:0032292) | 2.31404218 |
| 160 | myelination in peripheral nervous system (GO:0022011) | 2.31404218 |
| 161 | cell-substrate junction assembly (GO:0007044) | 2.31322015 |
| 162 | otic vesicle formation (GO:0030916) | 2.30996216 |
| 163 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.30891368 |
| 164 | cell communication by electrical coupling (GO:0010644) | 2.30627092 |
| 165 | cell proliferation involved in metanephros development (GO:0072203) | 2.30344005 |
| 166 | regulation of fatty acid oxidation (GO:0046320) | 2.30326625 |
| 167 | striated muscle hypertrophy (GO:0014897) | 2.29866065 |
| 168 | positive regulation of tolerance induction (GO:0002645) | 2.28856884 |
| 169 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27335417 |
| 170 | cellular potassium ion homeostasis (GO:0030007) | 2.26472540 |
| 171 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.25762285 |
| 172 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.25646660 |
| 173 | regulation of triglyceride catabolic process (GO:0010896) | 2.25354469 |
| 174 | T cell costimulation (GO:0031295) | 2.25240380 |
| 175 | negative regulation of cell fate specification (GO:0009996) | 2.24929914 |
| 176 | axon ensheathment in central nervous system (GO:0032291) | 2.24864222 |
| 177 | central nervous system myelination (GO:0022010) | 2.24864222 |
| 178 | osteoblast development (GO:0002076) | 2.24737101 |
| 179 | regulation of cardioblast differentiation (GO:0051890) | 2.24734829 |
| 180 | positive regulation of humoral immune response (GO:0002922) | 2.24696169 |
| 181 | basement membrane organization (GO:0071711) | 2.24656339 |
| 182 | apoptotic process involved in morphogenesis (GO:0060561) | 2.24609407 |
| 183 | cGMP-mediated signaling (GO:0019934) | 2.24366444 |
| 184 | regulation of hypersensitivity (GO:0002883) | 2.24265519 |
| 185 | JAK-STAT cascade (GO:0007259) | 2.24230216 |
| 186 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.23967494 |
| 187 | natural killer cell differentiation (GO:0001779) | 2.23625329 |
| 188 | positive regulation of protein deacetylation (GO:0090312) | 2.23267299 |
| 189 | positive regulation of sterol transport (GO:0032373) | 2.21720603 |
| 190 | positive regulation of cholesterol transport (GO:0032376) | 2.21720603 |
| 191 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.20290828 |
| 192 | lymphocyte costimulation (GO:0031294) | 2.17620884 |
| 193 | regulation of tolerance induction (GO:0002643) | 2.17279306 |
| 194 | positive regulation of lipid catabolic process (GO:0050996) | 2.16708706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.36318096 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.31615340 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.46240031 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.18613022 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.85230069 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.83602463 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83399389 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69787110 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.64247434 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.60779790 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56243222 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.50970262 |
| 13 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49321586 |
| 14 | * MYC_22102868_ChIP-Seq_BL_Human | 2.48832140 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41500163 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37175509 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33667062 |
| 18 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29821402 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.23998567 |
| 20 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.22199302 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21796323 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19994113 |
| 23 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.17574568 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.14427786 |
| 25 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.13062923 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.09985777 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.09872749 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.06761725 |
| 29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06258796 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06146754 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04683337 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01887047 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.98022835 |
| 34 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97629786 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96728517 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95521314 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91711152 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.91327888 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.91188098 |
| 40 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.88259701 |
| 41 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.88259701 |
| 42 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.88259701 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87300200 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82976748 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81099648 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80965261 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.80962307 |
| 48 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.80049522 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79645385 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77514902 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.77416851 |
| 52 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76662874 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.75367662 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.75367662 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74255949 |
| 56 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72886664 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.72159037 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.71477849 |
| 59 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.70884166 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68280591 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66994256 |
| 62 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.63585315 |
| 63 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61646135 |
| 64 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60069564 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58524812 |
| 66 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.57537585 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57178201 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56177721 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.54697461 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54267764 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52256531 |
| 72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51926478 |
| 73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50315585 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.49460227 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49026297 |
| 76 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.48975971 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43974094 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43254780 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42945672 |
| 80 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42391678 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40970129 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38842055 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.38819161 |
| 84 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38128043 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.37234949 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36761095 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35633916 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34392435 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33842730 |
| 90 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31241088 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30833201 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30245525 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.30012056 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29669443 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28798297 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27710422 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25531171 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25265551 |
| 99 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25137550 |
| 100 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25121577 |
| 101 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25001267 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24911332 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24750299 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24607070 |
| 105 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.22919608 |
| 106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21870030 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21285075 |
| 108 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.20881263 |
| 109 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19573349 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19433769 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19418376 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19313781 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17418699 |
| 114 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17331148 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17040819 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16817432 |
| 117 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15791038 |
| 118 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15661190 |
| 119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.14814284 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14409415 |
| 121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.14090412 |
| 122 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13752566 |
| 123 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12947218 |
| 124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12000253 |
| 125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12000253 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11782967 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11778358 |
| 128 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.11615783 |
| 129 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.11058566 |
| 130 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10852194 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10683678 |
| 132 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10671956 |
| 133 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10623340 |
| 134 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.09505003 |
| 135 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09016643 |
| 136 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08003172 |
| 137 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07766679 |
| 138 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07415702 |
| 139 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07399684 |
| 140 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07166148 |
| 141 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05810166 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05397707 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04097265 |
| 144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04063306 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04030400 |
| 146 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03341938 |
| 147 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03287066 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00911792 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99506921 |
| 150 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98394340 |
| 151 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97456135 |
| 152 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97392384 |
| 153 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96229700 |
| 154 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95879888 |
| 155 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95226424 |
| 156 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94968932 |
| 157 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94030129 |
| 158 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89887637 |
| 159 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89211065 |
| 160 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86470955 |
| 161 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84752756 |
| 162 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84166757 |
| 163 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82724987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.15046147 |
| 2 | MP0004510_myositis | 2.90532884 |
| 3 | MP0002249_abnormal_larynx_morphology | 2.76878697 |
| 4 | MP0010030_abnormal_orbit_morphology | 2.74424121 |
| 5 | MP0000685_abnormal_immune_system | 2.71291766 |
| 6 | MP0000566_synostosis | 2.69920554 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.60370574 |
| 8 | MP0005623_abnormal_meninges_morphology | 2.56322289 |
| 9 | MP0001790_abnormal_immune_system | 2.52838345 |
| 10 | MP0005387_immune_system_phenotype | 2.52838345 |
| 11 | MP0003011_delayed_dark_adaptation | 2.47407511 |
| 12 | MP0003436_decreased_susceptibility_to | 2.47379718 |
| 13 | MP0003724_increased_susceptibility_to | 2.38777627 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.37092420 |
| 15 | MP0003303_peritoneal_inflammation | 2.31980015 |
| 16 | MP0001346_abnormal_lacrimal_gland | 2.29251548 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.20138930 |
| 18 | MP0001800_abnormal_humoral_immune | 2.19533236 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.19448632 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.13967208 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.10664038 |
| 22 | MP0005670_abnormal_white_adipose | 2.04779971 |
| 23 | MP0001853_heart_inflammation | 2.02306172 |
| 24 | MP0004272_abnormal_basement_membrane | 2.00400969 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.93551756 |
| 26 | MP0009840_abnormal_foam_cell | 1.93217386 |
| 27 | MP0002405_respiratory_system_inflammati | 1.92210661 |
| 28 | MP0004947_skin_inflammation | 1.90312678 |
| 29 | MP0002723_abnormal_immune_serum | 1.89188318 |
| 30 | MP0005360_urolithiasis | 1.88694685 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.88576870 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.84619529 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.84474196 |
| 34 | * MP0002452_abnormal_antigen_presenting | 1.81463378 |
| 35 | MP0000762_abnormal_tongue_morphology | 1.78654614 |
| 36 | MP0000534_abnormal_ureter_morphology | 1.78077284 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.77115280 |
| 38 | MP0004858_abnormal_nervous_system | 1.76187139 |
| 39 | MP0005671_abnormal_response_to | 1.75570641 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.68354336 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.66196722 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.65472914 |
| 43 | * MP0002420_abnormal_adaptive_immunity | 1.64269297 |
| 44 | MP0001873_stomach_inflammation | 1.63608693 |
| 45 | MP0001851_eye_inflammation | 1.62851678 |
| 46 | * MP0001819_abnormal_immune_cell | 1.62423901 |
| 47 | MP0000579_abnormal_nail_morphology | 1.61622171 |
| 48 | * MP0002419_abnormal_innate_immunity | 1.60368509 |
| 49 | MP0000749_muscle_degeneration | 1.59796477 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.59566512 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.58512551 |
| 52 | MP0009278_abnormal_bone_marrow | 1.57470946 |
| 53 | MP0005409_darkened_coat_color | 1.57201679 |
| 54 | MP0005025_abnormal_response_to | 1.55936868 |
| 55 | MP0002254_reproductive_system_inflammat | 1.54791319 |
| 56 | MP0005666_abnormal_adipose_tissue | 1.53743952 |
| 57 | MP0002796_impaired_skin_barrier | 1.53273268 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.52652346 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.50042015 |
| 60 | MP0009053_abnormal_anal_canal | 1.49930210 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.49484896 |
| 62 | MP0000733_abnormal_muscle_development | 1.48231833 |
| 63 | MP0003942_abnormal_urinary_system | 1.48025577 |
| 64 | MP0003091_abnormal_cell_migration | 1.47496063 |
| 65 | MP0004233_abnormal_muscle_weight | 1.47300806 |
| 66 | MP0003279_aneurysm | 1.47194084 |
| 67 | MP0000049_abnormal_middle_ear | 1.47046560 |
| 68 | MP0003941_abnormal_skin_development | 1.46328744 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.45831827 |
| 70 | MP0009785_altered_susceptibility_to | 1.45735142 |
| 71 | MP0006082_CNS_inflammation | 1.44386894 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.43967734 |
| 73 | MP0000609_abnormal_liver_physiology | 1.41932547 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.41679583 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.41537976 |
| 76 | MP0000747_muscle_weakness | 1.41260511 |
| 77 | MP0006138_congestive_heart_failure | 1.40650220 |
| 78 | MP0009250_abnormal_appendicular_skeleto | 1.39659410 |
| 79 | MP0002933_joint_inflammation | 1.39206618 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.38682544 |
| 81 | MP0000750_abnormal_muscle_regeneration | 1.38342490 |
| 82 | MP0005365_abnormal_bile_salt | 1.38294238 |
| 83 | MP0003950_abnormal_plasma_membrane | 1.37478593 |
| 84 | MP0009384_cardiac_valve_regurgitation | 1.37249601 |
| 85 | MP0002398_abnormal_bone_marrow | 1.37034567 |
| 86 | * MP0000716_abnormal_immune_system | 1.36378253 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 1.35909646 |
| 88 | MP0001845_abnormal_inflammatory_respons | 1.35197960 |
| 89 | MP0001849_ear_inflammation | 1.33890020 |
| 90 | MP0002006_tumorigenesis | 1.32626912 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 1.28627411 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 1.28240667 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 1.28035711 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.27760200 |
| 95 | MP0005257_abnormal_intraocular_pressure | 1.25461627 |
| 96 | MP0001299_abnormal_eye_distance/ | 1.24950693 |
| 97 | MP0000467_abnormal_esophagus_morphology | 1.23217170 |
| 98 | MP0000003_abnormal_adipose_tissue | 1.22987633 |
| 99 | MP0004130_abnormal_muscle_cell | 1.21457374 |
| 100 | MP0003252_abnormal_bile_duct | 1.21456207 |
| 101 | MP0003566_abnormal_cell_adhesion | 1.21083969 |
| 102 | MP0005423_abnormal_somatic_nervous | 1.20851518 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 1.20347786 |
| 104 | MP0000689_abnormal_spleen_morphology | 1.20230471 |
| 105 | MP0003828_pulmonary_edema | 1.19939595 |
| 106 | MP0002697_abnormal_eye_size | 1.19208703 |
| 107 | MP0002971_abnormal_brown_adipose | 1.19169335 |
| 108 | MP0005551_abnormal_eye_electrophysiolog | 1.19011439 |
| 109 | MP0003938_abnormal_ear_development | 1.18988409 |
| 110 | MP0009672_abnormal_birth_weight | 1.17856360 |
| 111 | MP0002722_abnormal_immune_system | 1.17808238 |
| 112 | MP0005275_abnormal_skin_tensile | 1.15983142 |
| 113 | MP0005369_muscle_phenotype | 1.15496931 |
| 114 | MP0003866_abnormal_defecation | 1.15422361 |
| 115 | MP0002116_abnormal_craniofacial_bone | 1.14594180 |
| 116 | MP0004036_abnormal_muscle_relaxation | 1.14141650 |
| 117 | MP0004808_abnormal_hematopoietic_stem | 1.13917982 |
| 118 | MP0000703_abnormal_thymus_morphology | 1.13598670 |
| 119 | MP0010329_abnormal_lipoprotein_level | 1.12461887 |
| 120 | MP0010368_abnormal_lymphatic_system | 1.11726595 |
| 121 | * MP0002998_abnormal_bone_remodeling | 1.11361657 |
| 122 | MP0005375_adipose_tissue_phenotype | 1.11253091 |
| 123 | MP0003136_yellow_coat_color | 1.10118132 |
| 124 | MP0002106_abnormal_muscle_physiology | 1.05686519 |
| 125 | * MP0002429_abnormal_blood_cell | 1.04366465 |
| 126 | MP0003045_fibrosis | 1.04355442 |
| 127 | MP0000516_abnormal_urinary_system | 1.03734331 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 1.03734331 |
| 129 | MP0008469_abnormal_protein_level | 1.01942025 |
| 130 | MP0002896_abnormal_bone_mineralization | 1.01917117 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 1.01705096 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 1.01231507 |
| 133 | MP0005620_abnormal_muscle_contractility | 1.01218492 |
| 134 | MP0003755_abnormal_palate_morphology | 1.01067070 |
| 135 | MP0001545_abnormal_hematopoietic_system | 1.00819432 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 1.00819432 |
| 137 | MP0005310_abnormal_salivary_gland | 1.00088917 |
| 138 | MP0002009_preneoplasia | 1.00050684 |
| 139 | MP0005085_abnormal_gallbladder_physiolo | 0.99618049 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.99096434 |
| 141 | MP0005451_abnormal_body_composition | 0.97937806 |
| 142 | MP0009115_abnormal_fat_cell | 0.96225248 |
| 143 | MP0002396_abnormal_hematopoietic_system | 0.96072248 |
| 144 | MP0002877_abnormal_melanocyte_morpholog | 0.95594994 |
| 145 | MP0000767_abnormal_smooth_muscle | 0.94867447 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.94282842 |
| 147 | MP0002060_abnormal_skin_morphology | 0.93382374 |
| 148 | MP0002118_abnormal_lipid_homeostasis | 0.92583168 |
| 149 | MP0000428_abnormal_craniofacial_morphol | 0.89587962 |
| 150 | MP0001340_abnormal_eyelid_morphology | 0.88657853 |
| 151 | MP0002282_abnormal_trachea_morphology | 0.88466824 |
| 152 | MP0000432_abnormal_head_morphology | 0.88169284 |
| 153 | MP0000249_abnormal_blood_vessel | 0.88063195 |
| 154 | MP0001243_abnormal_dermal_layer | 0.87956260 |
| 155 | MP0000343_altered_response_to | 0.87412258 |
| 156 | MP0003448_altered_tumor_morphology | 0.86749517 |
| 157 | MP0002269_muscular_atrophy | 0.86067701 |
| 158 | MP0003634_abnormal_glial_cell | 0.85396401 |
| 159 | MP0003879_abnormal_hair_cell | 0.85082424 |
| 160 | MP0003115_abnormal_respiratory_system | 0.85063844 |
| 161 | MP0005334_abnormal_fat_pad | 0.84385731 |
| 162 | MP0003075_altered_response_to | 0.83351517 |
| 163 | MP0000462_abnormal_digestive_system | 0.83200386 |
| 164 | MP0001958_emphysema | 0.83157945 |
| 165 | MP0001216_abnormal_epidermal_layer | 0.82450958 |
| 166 | MP0009764_decreased_sensitivity_to | 0.82375099 |
| 167 | MP0008569_lethality_at_weaning | 0.81368099 |
| 168 | MP0005330_cardiomyopathy | 0.81257452 |
| 169 | MP0002972_abnormal_cardiac_muscle | 0.80966155 |
| 170 | MP0000678_abnormal_parathyroid_gland | 0.80919376 |
| 171 | MP0003935_abnormal_craniofacial_develop | 0.80563910 |
| 172 | MP0001188_hyperpigmentation | 0.79449551 |
| 173 | MP0005023_abnormal_wound_healing | 0.79308720 |
| 174 | MP0004381_abnormal_hair_follicle | 0.78470425 |
| 175 | MP0002089_abnormal_postnatal_growth/wei | 0.77435148 |
| 176 | MP0005595_abnormal_vascular_smooth | 0.76998825 |
| 177 | MP0002932_abnormal_joint_morphology | 0.76951905 |
| 178 | MP0003646_muscle_fatigue | 0.76212957 |
| 179 | MP0010630_abnormal_cardiac_muscle | 0.75783011 |
| 180 | MP0005390_skeleton_phenotype | 0.75729922 |
| 181 | MP0003690_abnormal_glial_cell | 0.72619277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pigmentary retinal degeneration (HP:0001146) | 4.86527624 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 4.42566065 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.95440061 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 3.91831522 |
| 5 | Nemaline bodies (HP:0003798) | 3.89086134 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.84856367 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.78096371 |
| 8 | Distal lower limb muscle weakness (HP:0009053) | 3.74914875 |
| 9 | Obstructive sleep apnea (HP:0002870) | 3.67428273 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.66279352 |
| 11 | Myocardial infarction (HP:0001658) | 3.56692327 |
| 12 | Shallow orbits (HP:0000586) | 3.47515245 |
| 13 | Chorioretinal atrophy (HP:0000533) | 3.45003341 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32375633 |
| 15 | Stomatitis (HP:0010280) | 3.30468885 |
| 16 | Myositis (HP:0100614) | 3.22213486 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.14139985 |
| 18 | Orchitis (HP:0100796) | 3.11298205 |
| 19 | Abnormality of the fingertips (HP:0001211) | 3.09370789 |
| 20 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.94712814 |
| 21 | Broad metatarsal (HP:0001783) | 2.85779647 |
| 22 | Protrusio acetabuli (HP:0003179) | 2.84956204 |
| 23 | Turricephaly (HP:0000262) | 2.84265373 |
| 24 | Myopathic facies (HP:0002058) | 2.84018219 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 2.82671922 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.82241526 |
| 27 | Optic neuritis (HP:0100653) | 2.81414288 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 2.81414288 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.80111022 |
| 30 | Increased density of long bones (HP:0006392) | 2.74850288 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.74527894 |
| 32 | Coronal craniosynostosis (HP:0004440) | 2.73654574 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72807583 |
| 34 | Round ear (HP:0100830) | 2.72247341 |
| 35 | IgM deficiency (HP:0002850) | 2.69883717 |
| 36 | Bronchomalacia (HP:0002780) | 2.65512702 |
| 37 | Central scotoma (HP:0000603) | 2.62557999 |
| 38 | Scotoma (HP:0000575) | 2.61702727 |
| 39 | Persistence of primary teeth (HP:0006335) | 2.60194692 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.59255860 |
| 41 | Subaortic stenosis (HP:0001682) | 2.59255860 |
| 42 | Partial duplication of thumb phalanx (HP:0009944) | 2.57524062 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.55981681 |
| 44 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.55268108 |
| 45 | Partial duplication of the phalanx of hand (HP:0009999) | 2.55172899 |
| 46 | Spinal rigidity (HP:0003306) | 2.54938661 |
| 47 | Interstitial pulmonary disease (HP:0006530) | 2.54672061 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.54117865 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.53385599 |
| 50 | Arterial thrombosis (HP:0004420) | 2.53380212 |
| 51 | Colitis (HP:0002583) | 2.52810260 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.52790117 |
| 53 | Xanthomatosis (HP:0000991) | 2.47422066 |
| 54 | Ulnar bowing (HP:0003031) | 2.46126298 |
| 55 | Recurrent viral infections (HP:0004429) | 2.46095259 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.46090473 |
| 57 | Abnormality of the parietal bone (HP:0002696) | 2.45887524 |
| 58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.45699733 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.45108298 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.44374831 |
| 61 | Hyperacusis (HP:0010780) | 2.42353181 |
| 62 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41462433 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.41147370 |
| 64 | Chronic otitis media (HP:0000389) | 2.40791666 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.39637462 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.39308369 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.37948449 |
| 68 | T lymphocytopenia (HP:0005403) | 2.37479896 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.36347697 |
| 70 | Recurrent abscess formation (HP:0002722) | 2.34795917 |
| 71 | Vasculitis (HP:0002633) | 2.34622920 |
| 72 | Myoglobinuria (HP:0002913) | 2.34603795 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.34086683 |
| 74 | Aplasia of the phalanges of the hand (HP:0009802) | 2.34086683 |
| 75 | Aplasia involving bones of the extremities (HP:0009825) | 2.34086683 |
| 76 | Nasal polyposis (HP:0100582) | 2.33391102 |
| 77 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33307840 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.32965504 |
| 79 | Abnormality of T cell number (HP:0011839) | 2.32048284 |
| 80 | Broad face (HP:0000283) | 2.32025582 |
| 81 | Polycythemia (HP:0001901) | 2.29901759 |
| 82 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.27294142 |
| 83 | Pulmonary embolism (HP:0002204) | 2.27174757 |
| 84 | Cellulitis (HP:0100658) | 2.27139426 |
| 85 | Pustule (HP:0200039) | 2.26422230 |
| 86 | Depressed nasal tip (HP:0000437) | 2.26016999 |
| 87 | Peritonitis (HP:0002586) | 2.25335038 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.25197738 |
| 89 | Dyschromatopsia (HP:0007641) | 2.24344347 |
| 90 | Increased IgE level (HP:0003212) | 2.24248434 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 2.23366033 |
| 92 | Posterior subcapsular cataract (HP:0007787) | 2.22993007 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.22503127 |
| 94 | Muscle fiber splitting (HP:0003555) | 2.21884834 |
| 95 | Severe combined immunodeficiency (HP:0004430) | 2.21716866 |
| 96 | Neck muscle weakness (HP:0000467) | 2.20381088 |
| 97 | Calcaneovalgus deformity (HP:0001848) | 2.17005830 |
| 98 | Bulbar palsy (HP:0001283) | 2.15233116 |
| 99 | Complement deficiency (HP:0004431) | 2.13231905 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.12953149 |
| 101 | Recurrent skin infections (HP:0001581) | 2.12870420 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.12864949 |
| 103 | Cone-rod dystrophy (HP:0000548) | 2.10941245 |
| 104 | Gingival bleeding (HP:0000225) | 2.10869145 |
| 105 | Distal arthrogryposis (HP:0005684) | 2.10782227 |
| 106 | Neonatal short-limb short stature (HP:0008921) | 2.10266002 |
| 107 | Abnormality of the calf musculature (HP:0001430) | 2.10008655 |
| 108 | Pendular nystagmus (HP:0012043) | 2.10005965 |
| 109 | Distal lower limb amyotrophy (HP:0008944) | 2.09129348 |
| 110 | Hypoglycemic coma (HP:0001325) | 2.08861740 |
| 111 | Abnormality of T cells (HP:0002843) | 2.08562153 |
| 112 | Leukocytosis (HP:0001974) | 2.07143418 |
| 113 | Combined immunodeficiency (HP:0005387) | 2.05627453 |
| 114 | Ulnar deviation of the wrist (HP:0003049) | 2.05225714 |
| 115 | Difficulty running (HP:0009046) | 2.04875950 |
| 116 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.03767090 |
| 117 | Macular degeneration (HP:0000608) | 2.03594836 |
| 118 | Rhabdomyolysis (HP:0003201) | 2.03413711 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 2.02965012 |
| 120 | Sleep apnea (HP:0010535) | 2.01025251 |
| 121 | Joint hemorrhage (HP:0005261) | 1.99659620 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.98953715 |
| 123 | Increased connective tissue (HP:0009025) | 1.98827438 |
| 124 | Emphysema (HP:0002097) | 1.98000168 |
| 125 | Thyroiditis (HP:0100646) | 1.96646918 |
| 126 | Subcapsular cataract (HP:0000523) | 1.96603625 |
| 127 | Hematochezia (HP:0002573) | 1.96566758 |
| 128 | Thin ribs (HP:0000883) | 1.96188012 |
| 129 | Mediastinal lymphadenopathy (HP:0100721) | 1.95611744 |
| 130 | Calf muscle hypertrophy (HP:0008981) | 1.94158562 |
| 131 | Attenuation of retinal blood vessels (HP:0007843) | 1.93726273 |
| 132 | Atrioventricular block (HP:0001678) | 1.93561359 |
| 133 | Meningitis (HP:0001287) | 1.92738475 |
| 134 | Aplasia of the musculature (HP:0100854) | 1.91748790 |
| 135 | Esophageal varix (HP:0002040) | 1.91134063 |
| 136 | Hemoptysis (HP:0002105) | 1.90968431 |
| 137 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90531221 |
| 138 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90531221 |
| 139 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89982297 |
| 140 | Hypoplasia of the iris (HP:0007676) | 1.89191541 |
| 141 | Vascular tortuosity (HP:0004948) | 1.88733500 |
| 142 | Hypoalphalipoproteinemia (HP:0003233) | 1.88329622 |
| 143 | Fatigue (HP:0012378) | 1.87872395 |
| 144 | Recurrent bronchitis (HP:0002837) | 1.87695286 |
| 145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86452013 |
| 146 | Progressive visual loss (HP:0000529) | 1.86191829 |
| 147 | Aortic aneurysm (HP:0004942) | 1.85955485 |
| 148 | Epistaxis (HP:0000421) | 1.85920070 |
| 149 | Split foot (HP:0001839) | 1.85115295 |
| 150 | Abnormality of eosinophils (HP:0001879) | 1.84704943 |
| 151 | Abnormal platelet function (HP:0011869) | 1.83932738 |
| 152 | Abnormal atrioventricular conduction (HP:0005150) | 1.82991866 |
| 153 | Choanal stenosis (HP:0000452) | 1.82915820 |
| 154 | Axonal loss (HP:0003447) | 1.81732070 |
| 155 | Progressive muscle weakness (HP:0003323) | 1.81664360 |
| 156 | Absent phalangeal crease (HP:0006109) | 1.81132746 |
| 157 | Arnold-Chiari malformation (HP:0002308) | 1.80510105 |
| 158 | Achilles tendon contracture (HP:0001771) | 1.79958926 |
| 159 | Deformed tarsal bones (HP:0008119) | 1.76782886 |
| 160 | Diaphragmatic weakness (HP:0009113) | 1.76359123 |
| 161 | Premature rupture of membranes (HP:0001788) | 1.74558881 |
| 162 | Mitral regurgitation (HP:0001653) | 1.73887030 |
| 163 | Heart block (HP:0012722) | 1.73432810 |
| 164 | Asymmetric septal hypertrophy (HP:0001670) | 1.73109464 |
| 165 | Right ventricular cardiomyopathy (HP:0011663) | 1.72549988 |
| 166 | Limb-girdle muscle atrophy (HP:0003797) | 1.72356720 |
| 167 | Arterial tortuosity (HP:0005116) | 1.72348701 |
| 168 | Hyperkalemia (HP:0002153) | 1.71676259 |
| 169 | Muscle stiffness (HP:0003552) | 1.71594784 |
| 170 | Maternal diabetes (HP:0009800) | 1.71071012 |
| 171 | Generalized amyotrophy (HP:0003700) | 1.69356369 |
| 172 | Nasolacrimal duct obstruction (HP:0000579) | 1.68655010 |
| 173 | Sudden death (HP:0001699) | 1.67648542 |
| 174 | Difficulty climbing stairs (HP:0003551) | 1.67615708 |
| 175 | Skin pits (HP:0100276) | 1.67124135 |
| 176 | Camptodactyly of toe (HP:0001836) | 1.66584246 |
| 177 | Cerebral inclusion bodies (HP:0100314) | 1.66536050 |
| 178 | Bladder diverticulum (HP:0000015) | 1.66504159 |
| 179 | Laryngomalacia (HP:0001601) | 1.65546970 |
| 180 | Stridor (HP:0010307) | 1.65523565 |
| 181 | Bundle branch block (HP:0011710) | 1.64743733 |
| 182 | Lower limb amyotrophy (HP:0007210) | 1.64504931 |
| 183 | Abnormality of the salivary glands (HP:0010286) | 1.64246396 |
| 184 | Ventricular tachycardia (HP:0004756) | 1.63718209 |
| 185 | Scapular winging (HP:0003691) | 1.63639327 |
| 186 | Overriding aorta (HP:0002623) | 1.63621016 |
| 187 | Slender build (HP:0001533) | 1.61331523 |
| 188 | Athetosis (HP:0002305) | 1.61144955 |
| 189 | Bell-shaped thorax (HP:0001591) | 1.61025791 |
| 190 | EMG: neuropathic changes (HP:0003445) | 1.60665173 |
| 191 | Bifid scrotum (HP:0000048) | 1.60229330 |
| 192 | Germ cell neoplasia (HP:0100728) | 1.59413002 |
| 193 | Taurodontia (HP:0000679) | 1.58700870 |
| 194 | Abnormality of permanent molar morphology (HP:0011071) | 1.58700870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.05167875 |
| 2 | TXK | 2.70869810 |
| 3 | PRPF4B | 2.67448946 |
| 4 | MAP3K14 | 2.65167293 |
| 5 | EPHB1 | 2.62150310 |
| 6 | EPHA2 | 2.49406216 |
| 7 | TRIB3 | 2.42267578 |
| 8 | EEF2K | 2.26991915 |
| 9 | LATS2 | 2.24656731 |
| 10 | OBSCN | 2.24325345 |
| 11 | TAOK3 | 2.19915035 |
| 12 | SMG1 | 2.19760861 |
| 13 | ITK | 2.06265241 |
| 14 | ERN1 | 2.06250099 |
| 15 | STK10 | 2.01828603 |
| 16 | MAP3K10 | 2.01493017 |
| 17 | TYK2 | 1.96133256 |
| 18 | JAK3 | 1.94935296 |
| 19 | IRAK3 | 1.93567790 |
| 20 | TGFBR2 | 1.92345188 |
| 21 | FGFR4 | 1.83336065 |
| 22 | IKBKB | 1.82219611 |
| 23 | TBK1 | 1.81436100 |
| 24 | SIK1 | 1.80277829 |
| 25 | AKT3 | 1.77349824 |
| 26 | CHUK | 1.77343708 |
| 27 | IKBKE | 1.71775887 |
| 28 | EPHB2 | 1.68786554 |
| 29 | JAK1 | 1.67238761 |
| 30 | ICK | 1.65411288 |
| 31 | TTN | 1.63868114 |
| 32 | CDK12 | 1.61343117 |
| 33 | MAP2K3 | 1.60541857 |
| 34 | NLK | 1.59170618 |
| 35 | EPHA3 | 1.58299270 |
| 36 | PDGFRA | 1.49685255 |
| 37 | ZAP70 | 1.45805556 |
| 38 | PHKG2 | 1.39504763 |
| 39 | PHKG1 | 1.39504763 |
| 40 | BRD4 | 1.28060935 |
| 41 | FGFR3 | 1.25749939 |
| 42 | GRK6 | 1.21880952 |
| 43 | PIM1 | 1.21092964 |
| 44 | TEC | 1.18699206 |
| 45 | CAMK1D | 1.18256161 |
| 46 | MAPK15 | 1.16637695 |
| 47 | PTK6 | 1.16035422 |
| 48 | CSK | 1.15315690 |
| 49 | BTK | 1.13790291 |
| 50 | PKN2 | 1.12319299 |
| 51 | PNCK | 1.12002955 |
| 52 | MAP3K3 | 1.11904364 |
| 53 | UHMK1 | 1.09464782 |
| 54 | DDR2 | 1.09034950 |
| 55 | RPS6KC1 | 1.09026410 |
| 56 | RPS6KL1 | 1.09026410 |
| 57 | HIPK2 | 1.08184551 |
| 58 | PTK2 | 1.06999994 |
| 59 | DMPK | 1.06701439 |
| 60 | RPS6KA2 | 1.05369362 |
| 61 | NTRK1 | 1.02837775 |
| 62 | SGK223 | 1.02170532 |
| 63 | SGK494 | 1.02170532 |
| 64 | RPS6KA4 | 1.01161852 |
| 65 | CAMK1G | 0.98005201 |
| 66 | JAK2 | 0.96843548 |
| 67 | PRKAA2 | 0.94336636 |
| 68 | TAOK2 | 0.94218053 |
| 69 | IRAK4 | 0.93745624 |
| 70 | MARK1 | 0.93454898 |
| 71 | CDK9 | 0.93314213 |
| 72 | LRRK2 | 0.92879120 |
| 73 | HCK | 0.92853695 |
| 74 | MAP3K7 | 0.91824149 |
| 75 | KIT | 0.90942873 |
| 76 | GRK1 | 0.89945787 |
| 77 | LCK | 0.89415164 |
| 78 | RIPK1 | 0.88347694 |
| 79 | TRPM7 | 0.88061379 |
| 80 | PKN1 | 0.87278627 |
| 81 | PAK2 | 0.86598377 |
| 82 | TAOK1 | 0.84908780 |
| 83 | CLK1 | 0.82344433 |
| 84 | TYRO3 | 0.81911413 |
| 85 | DYRK1B | 0.81574345 |
| 86 | CSF1R | 0.80641204 |
| 87 | DYRK3 | 0.80632609 |
| 88 | TSSK6 | 0.78977232 |
| 89 | ROCK2 | 0.78451076 |
| 90 | MAPK7 | 0.77682969 |
| 91 | PDGFRB | 0.77305928 |
| 92 | MARK3 | 0.76862010 |
| 93 | GSK3A | 0.75947967 |
| 94 | MAPK12 | 0.75442520 |
| 95 | PRKD2 | 0.73430239 |
| 96 | PRKCH | 0.72645061 |
| 97 | RPS6KA5 | 0.72444396 |
| 98 | IRAK1 | 0.70503435 |
| 99 | SGK3 | 0.70028552 |
| 100 | BMX | 0.67626038 |
| 101 | SYK | 0.66717053 |
| 102 | AKT2 | 0.64332758 |
| 103 | PRKCQ | 0.62926897 |
| 104 | RPS6KA1 | 0.62576569 |
| 105 | CAMK2G | 0.61405878 |
| 106 | CDC42BPA | 0.61315632 |
| 107 | ABL2 | 0.60251077 |
| 108 | PRKD3 | 0.58326486 |
| 109 | NEK9 | 0.57872620 |
| 110 | KSR2 | 0.57617284 |
| 111 | MAP3K9 | 0.57448166 |
| 112 | MAPKAPK3 | 0.56400911 |
| 113 | MAPKAPK2 | 0.56175546 |
| 114 | CAMK4 | 0.55952282 |
| 115 | CAMK1 | 0.55728274 |
| 116 | MAPK10 | 0.52472683 |
| 117 | MTOR | 0.52121253 |
| 118 | PRKD1 | 0.51341788 |
| 119 | MAP2K2 | 0.50995815 |
| 120 | MKNK2 | 0.50917595 |
| 121 | FGFR2 | 0.50745814 |
| 122 | MAP3K13 | 0.50029980 |
| 123 | CAMK2B | 0.49197102 |
| 124 | WEE1 | 0.48542649 |
| 125 | MELK | 0.47925009 |
| 126 | BLK | 0.47886527 |
| 127 | STK24 | 0.47695101 |
| 128 | CDK6 | 0.47392601 |
| 129 | PDPK1 | 0.47155450 |
| 130 | SIK2 | 0.45750632 |
| 131 | SGK1 | 0.45718742 |
| 132 | PAK6 | 0.45304070 |
| 133 | IRAK2 | 0.44837190 |
| 134 | NTRK2 | 0.44586962 |
| 135 | MAPK4 | 0.43990276 |
| 136 | KDR | 0.43176000 |
| 137 | PIM2 | 0.40898977 |
| 138 | RPS6KA6 | 0.39947532 |
| 139 | LATS1 | 0.39832850 |
| 140 | MARK2 | 0.39044440 |
| 141 | STK11 | 0.39008817 |
| 142 | CAMK2D | 0.38878554 |
| 143 | PDK1 | 0.38697747 |
| 144 | BCKDK | 0.38508305 |
| 145 | MAPKAPK5 | 0.38004797 |
| 146 | STK4 | 0.37759498 |
| 147 | ROCK1 | 0.37324190 |
| 148 | MAPK3 | 0.37318726 |
| 149 | SGK2 | 0.37257136 |
| 150 | MAP3K1 | 0.36751542 |
| 151 | STK38 | 0.36137051 |
| 152 | MAPK9 | 0.35540556 |
| 153 | WNK1 | 0.35278706 |
| 154 | ABL1 | 0.34369172 |
| 155 | NME1 | 0.34256143 |
| 156 | PAK4 | 0.33287181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.95747120 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.49336731 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.41912843 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34122997 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.30844526 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98196828 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85963419 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85864939 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85558757 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84928341 |
| 11 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.83928231 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80333054 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.74916422 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70402017 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.66444673 |
| 16 | Tight junction_Homo sapiens_hsa04530 | 1.65075371 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.64083973 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.61667763 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54929880 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53849788 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.52917696 |
| 22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.52121153 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48966598 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47500393 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47015025 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46804544 |
| 27 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.46678904 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46131254 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44350062 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43471752 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.38851079 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.38262329 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.37768116 |
| 34 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.37747890 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34664623 |
| 36 | Melanogenesis_Homo sapiens_hsa04916 | 1.34409597 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.33835812 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33045116 |
| 39 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.32075612 |
| 40 | Thyroid cancer_Homo sapiens_hsa05216 | 1.32013018 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31526429 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.30796647 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30461531 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29207020 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.27197719 |
| 46 | Endometrial cancer_Homo sapiens_hsa05213 | 1.26581265 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22968944 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22105556 |
| 49 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.20639889 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19998616 |
| 51 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.19728662 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 1.18447467 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17675005 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17356257 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.17297435 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16968841 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 1.16815959 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.16278858 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15804896 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15502769 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.14801499 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 1.14635644 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.13717287 |
| 64 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.13025074 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12594710 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12515658 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 1.12381880 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12258295 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11913540 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10251448 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09491765 |
| 72 | Malaria_Homo sapiens_hsa05144 | 1.08555409 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06069355 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06038674 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04614798 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.04566724 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04019382 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03533806 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00106887 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00096043 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.99195978 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98637275 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98607131 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98054200 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97599867 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97162442 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96886699 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96877985 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96435037 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94540529 |
| 91 | Axon guidance_Homo sapiens_hsa04360 | 0.92528420 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92440697 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.91706764 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91357522 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91138587 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.88998272 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88310030 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87886381 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87698386 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.87457800 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.87283623 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86891827 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86654887 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86041827 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85744609 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84665434 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84528371 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84327612 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84137870 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83597410 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83243132 |
| 112 | Allograft rejection_Homo sapiens_hsa05330 | 0.81064979 |
| 113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80048310 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.79860807 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79751308 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78896332 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78437413 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77094275 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77015420 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.76906591 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76876784 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76857237 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74799947 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.73921886 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72882950 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72531883 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72221701 |
| 128 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69500986 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.69361834 |
| 130 | Tuberculosis_Homo sapiens_hsa05152 | 0.69219225 |
| 131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67959039 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67018035 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66369358 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66142969 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65482212 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65243080 |
| 137 | Melanoma_Homo sapiens_hsa05218 | 0.65168506 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63945618 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63497330 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62895210 |
| 141 | Peroxisome_Homo sapiens_hsa04146 | 0.62502720 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62306718 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60094959 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59190072 |
| 145 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59170158 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58910004 |
| 147 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58698202 |
| 148 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58660681 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57982193 |
| 150 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55773581 |
| 151 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55623221 |
| 152 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55265331 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.54827577 |
| 154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54827142 |
| 155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54126089 |
| 156 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53549839 |
| 157 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51587573 |
| 158 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51474623 |
| 159 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51397516 |
| 160 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51168184 |
| 161 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50732375 |
| 162 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49465875 |
| 163 | Amoebiasis_Homo sapiens_hsa05146 | 0.48692894 |
| 164 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47158428 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44112638 |
| 166 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44037996 |
| 167 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42966631 |
| 168 | Prostate cancer_Homo sapiens_hsa05215 | 0.41087068 |
| 169 | Shigellosis_Homo sapiens_hsa05131 | 0.40716303 |
| 170 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40348120 |
| 171 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39474407 |
| 172 | Salmonella infection_Homo sapiens_hsa05132 | 0.36686632 |

